Proteomics Reveal the Inhibitory Mechanism of Levodopa Against Esophageal Squamous Cell Carcinoma

• প্রধান লেখক: Zhenzhen Li (লেখক), Xin Li (লেখক), Xinyu He (লেখক), Xuechao Jia (লেখক), Xiaofan Zhang (লেখক), Bingbing Lu (লেখক), Jimin Zhao (লেখক), Jing Lu (লেখক), Lexia Chen (লেখক), Ziming Dong (লেখক), Kangdong Liu (লেখক), Zigang Dong (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Frontiers Media S.A., 2020-09-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

High recurrence rates and poor survival of patients with esophageal squamous cell carcinoma (ESCC) after treatment make ongoing research on chemoprevention drugs for ESCC particularly important. In this study, we screened a large number of FDA-approved drugs and found levodopa, a drug used to treat...